Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+1.02%
FTSE
+0.55%
N225
+0.23%
AXJO
+0.20%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Cellectar Biosciences News

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

2 days ago
benzinga.com

12 Health Care Stocks Moving In Monday's After-Market Session

3 days ago
benzinga.com

12 Health Care Stocks Moving In Wednesday's After-Market Session

29 days ago
benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

29 days ago
benzinga.com

What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained

Feature Image for interests on Biotech, Briefs, Healthcare, News from benzinga.com
29 days ago
businesswire.com

Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight to 2028 - ResearchAndMarkets.com

Feature Image for interests on Energy, Healthcare, Stock, Unknown Sector from businesswire.com
7 months ago
finance.yahoo.com

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131

Feature Image for interests on Bing-Neel Syndrome, Biosciences, Clover Wam, Clrb from finance.yahoo.com
10 months ago
finance.yahoo.com

Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop onWaldenstrom’s Macroglobulinemia

Feature Image for interests on Andrei Shustov, Biopharmaceutical Company, Cellectar Biosciences, Central Nervous System from finance.yahoo.com
10 months ago
finance.yahoo.com

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update

Feature Image for interests on Biopharmaceutical Company, Healthcare, Refractory Patients, Response Categories from finance.yahoo.com
11 months ago
finance.yahoo.com

UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024

Feature Image for interests on Biopharmaceutical Company, Healthcare, Proprietary Drugs, Stock from finance.yahoo.com
11 months ago
Stocks
Health Care
clrb
Cellectar Biosciences
CLRB
+0.07 (+1.48%)
4.8
USD
At close at Jul 03, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

Cellectar Biosciences: Key Developments and Future Prospects for Stock Growth

3 days ago
publisher logo
Cashu

Cellectar Biosciences' PEL Technology: Advancing Targeted Cancer Treatment and Patient Outcomes

28 days ago
publisher logo
Cashu

Cellectar Biosciences: Pioneering Targeted Alpha Therapy in Cancer Treatment Revolution

6 months ago